MGMaria Galvez-Llompart

Maria Galvez-Llompart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Galvez-Llompart has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning- and AI-Driven QSAR Models for the Discovery of Novel Potential Fungicides: FAPI (Fungicide Targeting Acid Phosphatase Inhibition)

    by María Gálvez-Llompart, Riccardo Zanni, Yandira Morales, Álvaro Polonio, Dolores Fernández-Ortuño, Alejandro Pérez-García, Facundo Pérez-Giménez

    Fungal pathogens like Podosphaera xanthii (powdery mildew) and Botrytis cinerea (gray mold) cause significant agricultural losses, with fungicide resistance escalating due to the overreliance on conventional treatments. Consequently, the development of sustainable alternatives with novel modes of action is imperative for future crop protection. Acid phosphatases (APs), which play a key role in fungal phosphate metabolism and virulence, have emerged as promising molecular targets. To accelerate the identification of fungicides targeting acid phosphatase inhibition (FAPI), machine learning (ML), and artificial intelligence (AI)-driven quantitative structure-activity relationship (QSAR) models incorporating topological molecular descriptors have been employed to predict fungicidal activity. The experimental validation of the predicted candidates highlights the promising potential of these novel fungicides and underscores the value of ML- and AI-based QSAR methodologies in the development of next-generation, resistance-breaking fungicidal agents.


  • Open Access

    Lessons from Failed Attempts of Computationally Guided Synthesis of Aluminosilicate STF and IFR Zeolites in Hydroxide Media

    by Omer F. Altundal, Maria Galvez-Llompart, Angel Cantin, José Valero, Susana Valencia, Fernando Rey, Kingsley Christian Kemp, Suk Bong Hong, Frits Daeyaert, German Sastre

    Although zeolites are primarily aluminosilicates in terms of chemical composition, not all zeotypes have been successfully synthesized as aluminosilicates to date. This study aims to contribute answering the long-standing question of why some zeotypes cannot, or have not yet been, synthesized as aluminosilicates, using a computational approach that combines big data, artificial intelligence, accurate descriptors, and an algorithm for designing quaternary ammonium organic structure-directing agents (OSDAs) that help lower the total energy of the zeolite-OSDA system. The use of the synthesis energy descriptor enables evaluation of the reaction energy from gel monomers to the final zeolite product, including the occluded OSDA, while also accounting for the energetic contributions of framework aluminum, representing an improvement over previous models based on pure silica. The focus is on STF and IFR zeolites, whose synthesis in hydroxide media typically results in products with very high silicon to aluminum ratios. More than 10000 OSDAs, either designed or retrieved from existing databases, were evaluated under conditions likely to favor the formation of STF or IFR, and the corresponding synthesis energies were calculated for STF, IFR, and approximately 20 other competing zeolite phases. The computational results show that AEI, CHA, and a few other zeolites are consistently more energetically favorable, regardless of the OSDA used. This is explained by the increasing stability of phases as the aluminum content increases. Experimental synthesis using a shortlist of OSDAs predicted to favor STF or IFR, in addition to AEI or CHA, did not yield the expected aluminosilicate products, and instead, amorphous materials were obtained in most cases. While further refinement of computational tools is needed to better reflect experimental synthesis conditions, the results provide valuable insight and justification for the difficulty of synthesizing aluminosilicate STF and IFR in hydroxide media.


  • Open Access

    Targeting bacterial growth in biofilm conditions: rational design of novel inhibitors to mitigate clinical and food contamination using QSAR

    by Maria Galvez-Llompart, Jesús Hierrezuelo, Mariluz Blasco, Riccardo Zanni, Jorge Galvez, Antonio de Vicente, Alejandro Pérez-García, Diego Romero

    Antimicrobial resistance (AMR) is a pressing global issue exacerbated by the abuse of antibiotics and the formation of bacterial biofilms, which cause up to 80% of human bacterial infections. This study presents a computational strategy to address AMR by developing three novel quantitative structure–activity relationship (QSAR) models based on molecular topology to identify potential anti-biofilm and antibacterial agents. The models aim to determine the chemo-topological pattern of Gram (+) antibacterial, Gram (−) antibacterial, and biofilm formation inhibition activity. The models were applied to the virtual screening of a commercial chemical database, resulting in the selection of 58 compounds. Subsequent in vitro assays showed that three of these compounds exhibited the most promising antibacterial activity, with potential applications in enhancing food and medical device safety.


  • Open Access

    Rational Design of a Potential New Nematicide Targeting Chitin Deacetylase

    by Maria Galvez-Llompart, Riccardo Zanni, David Vela-Corcía, Álvaro Polonio, Facundo Perez-Gimenez, Jesús Martínez-Cruz, Diego Romero, Dolores Fernández-Ortuño, Alejandro Pérez-García, Jorge Galvez

    In a previously published study, the authors devised a molecular topology QSAR (quantitative structure-activity relationship) approach to detect novel fungicides acting as inhibitors of chitin deacetylase (CDA). Several of the chosen compounds exhibited noteworthy activity. Due to the close relationship between chitin-related proteins present in fungi and other chitin-containing plant-parasitic species, the authors decided to test these molecules against nematodes, based on their negative impact on agriculture. From an overall of 20 fungal CDA inhibitors, six showed to be active against Caenorhabditis elegans. These experimental results made it possible to develop two new molecular topology-based QSAR algorithms for the rational design of potential nematicides with CDA inhibitor activity for crop protection. Linear discriminant analysis was employed to create the two algorithms, one for identifying the chemo-mathematical pattern of commercial nematicides and the other for identifying nematicides with activity on CDA. After creating and validating the QSAR models, the authors screened several natural and synthetic compound databases, searching for alternatives to current nematicides. Finally one compound, the N2-(dimethylsulfamoyl)-N-{2-[(2-methyl-2-propanyl)-sulfanyl]-ethyl}-N2-phenylglycinamide or nematode chitin deacetylase inhibitor, was selected as the best candidate and was further investigated both in silico, through molecular docking and molecular dynamic simulations, and in vitro, through specific experimental assays. The molecule shows favorable binding behavior on the catalytic pocket of C. elegans CDA and the experimental assays confirm potential nematicide activity.


  • Open Access

    Rational Design of Chitin Deacetylase Inhibitors for Sustainable Agricultural Use Based on Molecular Topology

    by Riccardo Zanni, Jesús Martínez-Cruz, María Gálvez-Llompart, Dolores Fernández-Ortuño, Diego Romero, Ramón García-Domènech, Alejandro Pérez-García, Jorge Gálvez

    Fungicide resistance is a major concern in modern agriculture; therefore, there is a pressing demand to develop new, greener chemicals. Chitin is a major component of the fungal cell wall and a well-known elicitor of plant immunity. To overcome chitin recognition, fungal pathogens developed different strategies, with chitin deacetylase (CDA) activity being the most conserved. This enzyme is responsible for hydrolyzing the N-acetamido group in N-acetylglucosamine units of chitin to convert it to chitosan, a compound that can no longer be recognized by the plant. In previous works, we observed that treatments with CDA inhibitors, such as carboxylic acids, reduced the symptoms of cucurbit powdery mildew and induced rapid activation of chitin-triggered immunity, indicating that CDA could be an interesting target for fungicide development. In this work, we developed an in silico strategy based on QSAR (quantitative structure-activity relationship) and molecular topology (MT) to discover new, specific, and potent CAD inhibitors. Starting with the chemical structures of few carboxylic acids, with and without disease control activity, three predictive equations based on the MT paradigm were developed to identify a group of potential molecules. Their fungicidal activity was experimentally tested, and their specificity as CDA inhibitors was studied for the three best candidates by molecular docking simulations. To our knowledge, this is the first time that MT has been used for the identification of potential CDA inhibitors to be used against resistant powdery mildew strains. In this sense, we consider of special interest the discovery of molecules capable of stimulating the immune system of plants by triggering a defensive response against fungal species that are highly resistant to fungicides such as powdery mildew.


  • Open Access

    COVID-19 and the Importance of Being Prepared: A Multidisciplinary Strategy for the Discovery of Antivirals to Combat Pandemics

    by Maria Galvez-Llompart, Riccardo Zanni, Jorge Galvez, Subhash C. Basak, Sagar M. Goyal

    During an emergency, such as a pandemic in which time and resources are extremely scarce, it is important to find effective and rapid solutions when searching for possible treatments. One possibility in this regard is the repurposing of available “on the market” drugs. This is a proof of the concept study showing the potential of a collaboration between two research groups, engaged in computer-aided drug design and control of viral infections, for the development of early strategies to combat future pandemics. We describe a QSAR (quantitative structure activity relationship) based repurposing study on molecular topology and molecular docking for identifying inhibitors of the main protease (Mpro) of SARS-CoV-2, the causative agent of COVID-19. The aim of this computational strategy was to create an agile, rapid, and efficient way to enable the selection of molecules capable of inhibiting SARS-CoV-2 protease. Molecules selected through in silico method were tested in vitro using human coronavirus 229E as a surrogate for SARS-CoV-2. Three strategies were used to screen the antiviral activity of these molecules against human coronavirus 229E in cell cultures, e.g., pre-treatment, co-treatment, and post-treatment. We found >99% of virus inhibition during pre-treatment and co-treatment and 90–99% inhibition when the molecules were applied post-treatment (after infection with the virus). From all tested compounds, Molport-046-067-769 and Molport-046-568-802 are here reported for the first time as potential anti-SARS-CoV-2 compounds.


  • Open Access

    How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease

    by Maria Galvez-Llompart, Riccardo Zanni, Ramon Garcia-Domenech, Jorge Galvez

    Even if amyotrophic lateral sclerosis is still considered an orphan disease to date, its prevalence among the population is growing fast. Despite the efforts made by researchers and pharmaceutical companies, the cryptic information related to the biological and physiological onset mechanisms, as well as the complexity in identifying specific pharmacological targets, make it almost impossible to find effective treatments. Furthermore, because of complex ethical and economic aspects, it is usually hard to find all the necessary resources when searching for drugs for new orphan diseases. In this context, computational methods, based either on receptors or ligands, share the capability to improve the success rate when searching and selecting potential candidates for further experimentation and, consequently, reduce the number of resources and time taken when delivering a new drug to the market. In the present work, a computational strategy based on Molecular Topology, a mathematical paradigm capable of relating the chemical structure of a molecule to a specific biological or pharmacological property by means of numbers, is presented. The result was the creation of a reliable and accessible tool to help during the early in silico stages in the identification and repositioning of potential hits for ALS treatment, which can also apply to other orphan diseases. Considering that further computational and experimental results will be required for the final identification of viable hits, three linear discriminant equations combined with molecular docking simulations on specific proteins involved in ALS are reported, along with virtual screening of the Drugbank database as a practical example. In this particular case, as reported, a clinical trial has been already started for one of the drugs proposed in the present study.


  • Open Access

    Targeting the JAK/STAT Pathway: A Combined Ligand- and Target-Based Approach

    by Maria Galvez-Llompart, Riccardo Ocello, Laura Rullo, Serena Stamatakos, Irene Alessandrini, Riccardo Zanni, Iñaki Tuñón, Andrea Cavalli, Sanzio Candeletti, Matteo Masetti, et al.

    Janus kinases (JAKs) are a family of proinflammatory enzymes able to mediate the immune responses and the inflammatory cascade by modulating multiple cytokine expressions as well as various growth factors. In the present study, the inhibition of the JAK–signal transducer and activator of transcription (STAT) signaling pathway is explored as a potential strategy for treating autoimmune and inflammatory disorders. A computationally driven approach aimed at identifying novel JAK inhibitors based on molecular topology, docking, and molecular dynamics simulations was carried out. For the best candidates selected, the inhibitory activity against JAK2 was evaluated in vitro. Two hit compounds with a novel chemical scaffold, 4 (IC50 = 0.81 μM) and 7 (IC50 = 0.64 μM), showed promising results when compared with the reference drug Tofacitinib (IC50 = 0.031 μM).


  • Computational analysis of macrolides as SARS-CoV-2 main protease inhibitors: a pattern recognition study based on molecular topology and validated by molecular docking

    by Riccardo Zanni, Maria Galvez-Llompart, Jorge Galvez

    Since the outbreak of the current SARS-CoV-2 pandemic, much has been discussed about the effectiveness of treatments based on hydroxychloroquine combined with azithromycin or another macrolide. However, few articles have dealt with the possibility of using macrolides alone in treating the disease. In the present article, the authors’ hypothesis centers on the possibility that macrolides are effective against SARS-CoV-2 by inhibiting the virus protease. In support of this hypothesis, significant results are collected by following an in silico strategy based on a combination of molecular topology and docking. The results are in accordance with recent clinical data generated during the pandemic which indicate that macrolides are capable of significantly reducing the viral load, reinforcing the necessity of further clinical trials. Among the most effective macrolides identified by molecular topology are azithromycin, clarithromycin, lexithromycin, flurithromycin and neutramycin.